指南与共识呼吸衰竭与机械通气重症综合管理与镇静镇痛

疑似或确诊COVID-19患者转运医学学会共识指南

The Transport Medicine Society Consensus Guidelines for the Transport of Suspected or Confirmed COVID-19 Patients.
指南 / 共识 · Indian J Crit Care Med · 2020-01-01
一句话结论转运医学学会发布共识指南,针对疑似或确诊COVID-19成人患者的院内及院际安全转运提出推荐。

该共识指南由转运医学学会制定,适用于疑似或确诊COVID-19成人患者的诊断或治疗性转运,包括院内、院际转运及从外院转入医疗机构。指南强调COVID-19患者转运除疾病本身风险外,还存在向转运团队传播的风险,病毒可通过呼吸道飞沫人际传播。转运危重或感染性患者涉及多学科团队整合、设备与沟通等多因素,不良事件可源于团队协作不足、设备缺失或转运中故障等。指南建议由训练有素的转运团队进行适当规划,以保障安全转运。该指南需与COVID-19医疗管理指南及当地政策联合使用。

要点

  • 指南适用于疑似或确诊COVID-19成人患者的院内、院际转运及外院转入医疗机构的转运。
  • COVID-19患者转运除疾病本身风险外,还存在向转运团队传播的风险,病毒可经呼吸道飞沫人际传播。
  • 转运危重或感染性患者涉及多学科团队整合与人力调配,不良事件可源于团队沟通不足、设备缺失或转运中故障。
  • 训练有素的转运团队进行适当规划是疑似或确诊COVID-19患者安全转运的关键。
  • 指南推荐应与COVID-19医疗管理指南、当地工作场所政策及转诊与接收医院间协议联合使用。

适用人群与场景

  • 疑似或确诊COVID-19成人患者,需因诊断或治疗目的进行院内或院际转运,或从外院转运至医疗机构。

处置流程与药物剂量

  • 由训练有素的转运团队进行适当规划,以实现疑似或确诊COVID-19患者的安全转运。
  • 参与转运疑似或确诊COVID-19患者的人员面临感染风险,需采取适当步骤保障其安全。

研究设计与关键结果

  • 转运医学学会制定共识指南,针对疑似或确诊COVID-19成人患者的安全转运提出推荐。
  • 指南指出转运危重或感染性患者涉及多学科团队与人力整合,不良事件可归因于团队沟通不足、设备缺失或转运中故障,以及患者疾病固有的生理改变。
  • COVID-19患者转运除疾病本身风险外,还携带向转运团队传播的风险,病毒可经呼吸道飞沫人际传播。

证据类型、等级与局限

  • 证据类型:共识指南。
  • 指南声明适用于疑似或确诊COVID-19成人患者的安全转运,应与COVID-19医疗管理指南及建议联合使用,并需根据工作场所当地政策及转诊与接收医院间协议进行调整。
  • 随着新科学证据出现,该指南可能需要修改。

对床旁实践的改变

  • 作者认为训练有素的转运团队进行适当规划是疑似或确诊COVID-19患者安全转运的关键。
  • 指南推荐应与COVID-19医疗管理指南、当地工作场所政策及转诊与接收医院间协议联合使用。

指南或共识出处

  • 转运医学学会共识指南(The Transport Medicine Society Consensus Guidelines for the Transport of Suspected or Confirmed COVID-19 Patients),发表于Indian Journal of Critical Care Medicine,2020年。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

UNLABELLED: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19) and has been declared as a pandemic. COVID-19 patients may require transport for diagnostic or therapeutic purposes intra- or interhospital or transport from an outside hospital to a healthcare facility. Transport of critically ill or infectious patients is always challenging and involves the integration of various tasks and manpower. The adverse events have been attributed to various factors such as a multidisciplinary team and lack of appropriate communication among team members, absence of equipment, or failure during transport, apart from physiological alteration inherent to the disease of the patient. The transport of COVID-19 patients carries an additional risk of not only the disease itself but also due to the risk of its transmission to the transport team. The human-to-human transmission of the virus can occur via respiratory droplets. So, the person involved in the transport of such patients shall be at risk and warrants appropriate steps for their safety. Appropriate planning by a well-trained transport team is an essence for the safe transport of the suspected or confirmed COVID-19 patients. The Transport Medicine Society guidelines present consensus guidelines for the safe transport of COVID-19 patients.

DISCLAIMER: These consensus guidelines are applicable for the safe transport of suspected or confirmed COVID-19 adult patients. These recommendations should be used in conjunction with medical management guidelines and advisories related to COVID-19. These recommendations should be adapted to the local policies prevalent at the workplace and also per agreement among the hospitals for transport (agreement between referring and receiving facilities). With the emergence of new scientific evidence, these guidelines may require modification.

HOW TO CITE THIS ARTICLE: Munjal M, Ahmed SM, Garg R, Das S, Chatterjee N, Mittal K, et al. The Transport Medicine Society Consensus Guidelines for the Transport of Suspected or Confirmed COVID-19 Patients. Indian J Crit Care Med 2020;24(9):763-770.

来源:Indian J Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Munjal M, Ahmed SM, Garg R, et al. The Transport Medicine Society Consensus Guidelines for the Transport of Suspected or Confirmed COVID-19 Patients. Indian J Crit Care Med. 2020. PMID: 33132557. doi:10.5005/jp-journals-10071-23584

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。